Dr. Sanjiv Shah, MD

• Cardiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago Medical Center

  Fellowship Hospital, 2007

• Ucsf Medical Center|university Of California-san Francisco Medical Center

  Residency Hospital, 2003

• Ucsf Medical Center

  Internship Hospital, 2001

• Northwestern University Feinberg School Of Medicine

  Medical School, 2000

• English

• Dutch

• Association of Albuminuria With Cardiac Dysfunction in USA Hispanic Community, 2017-03-29

• Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study, 2022-02-18

• Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study, 2015-06-26

• Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction, 2019-10-14

• Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Early Results of the REBALANCE-HF Trial Roll-in Cohort, 2022-05-29

• MACROPHAGES IN HEART FAILURE WITH REDUCED VERSUS PRESERVED EJECTION FRACTION, 2019-02-05

• Application of the H2FPEF Score to a Global Clinical Trial of Patients with Heart Failure with Preserved Ejection Fraction: The TOPCAT Trial, 2019-07-22

• Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction (From the NEAT-HFpEF Trial), 2019-02-23

• A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy, 2021-05-11

• Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy, 2020-02-12

• Right Ventricular Structure and Function Are Associated with Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study, 2016-12-28

• Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure with Preserved Ejection Fraction:Results from the PROMIS-HFpEF Study, 2020-10-09

• Application of Machine Learning to Determine Top Predictors of Non-calcified Coronary Burden in Psoriasis: an Observational Cohort Study., 2019-10-31

• Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease, 2022-04-28

• Prevalence of American Heart Association Heart Failure Stages in African-American and White Young and Middle Aged Adults: The CARDIA Study, 2019-09-11

• Differences in Cardiac Mechanics among Genetically At-Risk First-Degree Relatives: The DCM Precision Medicine Study, 2023-06-04

• Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and its Prognostic Value in Pulmonary Hypertension due to Left Heart Disease, 2018-03-23

• Diastolic Dysfunction in Individuals with Human Immunodeficiency Virus Infection Literature Review, Rationale and Design of the Characterizing Heart function on Anti-Retroviral Therapy (CHART) Study, 2018-03-02

• Repolarization Heterogeneity: Beyond the QT Interval, 2016-04-29

• Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure, 2022-05-20

• MR-derived right ventricular parameters can predict pulmonary hypertension, 2011-02-02

• Targeted Therapeutics for Transthyretin Cardiac Amyloidosis Proof that Precision Medicine in Heart Failure is a Possibility?, 2019-01-22

• Cardiovascular Biomarkers in the Prediction of Incident Heart Failure with Preserved and Reduced Ejection Fraction, 2018-03-01

• Phase II trials in heart failure: The role of cardiovascular imaging, 2013-05-13

• Association of Low-Grade Albuminuria with Adverse Cardiac Mechanics: Findings from the HyperGEN Study, 2013-09-27

• Glucose dysregulation and subclinical cardiac dysfunction in older adults: The Cardiovascular Health Study, 2022-06-20

• Diastolic Dysfunction in Patients with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results from the CHART Study, 2019-11-02

• Developing Therapies for Heart Failure with Preserved Ejection Fraction: Current State and Future Directions, 2014-05-02

• GWAS of the electrocardiographic QT interval in Hispanics/Latinos generalizes previously identified loci and identifies population-specific signals, 2017-12-06

• Albuminuria, Kidney Function and Sudden Cardiac Death: Findings from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study, 2016-08-11

• Why We Should Care About Who Cares for Heart Failure with Preserved Ejection Fraction Patients, 2022-08-08

• Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study, 2021-03-01

• Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction, 2017-07-05

• Could A Low-Dose Combination "Polypill” Improve Outcomes in Heart Failure with Preserved Ejection Fraction?, 2021-03-05

• Association of the Frontal QRS-T Angle with Adverse Cardiac Remodeling, Impaired Left and Right Ventricular Function, and Worse Outcomes in Heart Failure with Preserved Ejection Fraction, 2013-09-27

• Elevated plasma ceramides are associated with antiretroviral therapy use and progression of carotid artery atherosclerosis in HIV infection, 2019-04-23

• Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction, 2020-10-07

• Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure with Preserved Ejection Fraction (INDIE-HFpEF): Rationale and Design, 2017-04-26

• PHENOTYPE-SPECIFIC TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION: A MULTIORGAN ROADMAP, 2016-07-05

• Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms, 2021-05-11

• Whole exome analyses to examine the impact of rare variants on left ventricular traits in African American participants from the HyperGEN and GENOA studies, 2017-07-20

• Inorganic vs. Organic Nitrates for HFpEF: It's Not All in Your Head!, 2017-09-11

• Exercise Intolerance in Older Adults with Heart Failure with Preserved Ejection Fraction: JACC State-of-the-art Review, 2021-09-14

• Association of Pericardial Fat with Cardiac Structure, Function and Mechanics: the Multi-Ethnic Study of Atherosclerosis, 2022-01-19

• The Role of Splanchnic Congestion and the Intestinal Microenvironment in the Pathogenesis of Advanced Heart Failure, 2019-01-16

• Parent-of-origin effects on quantitative phenotypes in a large Hutterite pedigree, 2019-01-18

• Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation, 2016-12-09

• Biomarker Profile of Left Atrial Myopathy in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial, 2019-12-17

• Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction, 2020-05-01

• Rare Genetic Variants Associated With Myocardial Fibrosis: Multi-Ethnic Study of Atherosclerosis, 2022-02-21

• Challenges of Cardio-kidney Composite Outcomes in Large-Scale Clinical Trials, 2021-01-07

• Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets, 2021-04-17

• Association of Hyper-polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction, 2021-10-22

• Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis, 2013-03-14

• Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction, 2016-01-20

• Research Priorities for Heart Failure with Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary, 2020-03-23

• Vulnerable Blood in High Risk Vascular Patients: Study Design and Methods, 2014-04-08

• A Risk-Based Approach for the Prediction and Prevention of Heart Failure, 2021-02-04

• Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans, 2019-08-13

• Time Resolved MRA: Evaluation of Intrapulmonary Circulation Parameters in Pulmonary Arterial Hypertension, 2010-10-21

• Differential Associations of Chronic Inflammatory Diseases with Incident Heart Failure, 2020-04-08

• Association of Patterns of Change in Adiposity with Diastolic Function and Systolic Myocardial Mechanics from Early Adulthood to Middle Age: The Coronary Artery Risk Development in Young Adults Study, 2018-09-01

• Clinical Correlates and Heritability of Cardiac Mechanics: The HyperGEN Study, 2018-07-11

• Generation of human iPSCs from urine derived cells of a non-affected control subject, 2016-12-09

• Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER, 2022-11-07

• Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction, 2014-05-22

• Temporal Trends in Prevalence & Prognostic Implications of Comorbidities among Patients with Acute Decompensated Heart Failure: the ARIC Study Community Surveillance, 2020-06-03

• Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA Study, 2021-05-25

• Development and Validation of a Long-Term Incident Heart Failure Risk Model, 2021-12-10

• Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure, 2022-03-31

• Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy, 2020-10-12

• Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial, 2020-01-11

• Distribution of 10-and 30-year predicted risks for heart failure in the United States population: NHANES 2015-2018, 2022-04-04

• Characterization of the Progression from Ambulatory to Hospitalized Heart Failure with Preserved Ejection Fraction, 2020-08-19

• Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus-results from the randomized, double-blind, placebo-controlled EmDia trial, 2023-02-10

• Baseline Characteristics of Patients in the PARALLAX Trial:Insights into Quality of Life and Exercise Capacity in Heart Failure with Preserved Ejection Fraction, 2021-07-26

• Prognostic Importance of Left Ventricular Mechanical Dyssynchrony in Heart Failure With Preserved Ejection Fraction, 2017-03-21

• Association between Myocardial Strain and Frailty in the Cardiovascular Health Study, 2021-05-17

• Application of Guideline-Based Echocardiographic Assessment of Left Atrial Pressure to Heart Failure with Preserved Ejection Fraction, 2021-01-21

• 4D Flow Assessment of Pulmonary Artery Flow and Wall Shear Stress in Adult Pulmonary Arterial Hypertension: Results from Two Institutions, 2014-06-27

• Community walking speed, sedentary or lying down time, and mortality in peripheral artery disease, 2016-02-12

• Predictors and Outcomes of Heart Failure with Mid-Range Ejection Fraction, 2017-12-11

• Associations of Cardiac Mechanics with Exercise Capacity: The Multi-Ethnic Study of Atherosclerosis, 2021-05-13

• Association of liver stiffness and cardiovascular outcomes in patients with heart failure: A systematic review and meta-analysis, 2018-10-30

• Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial, 2021-11-15

• Race/Ethnicity and Prevalence of Aortic Stenosis by Echocardiography in the Multi-Ethnic Study of Atherosclerosis, 2021-05-11

• Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials, 2018-10-08

• History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure, 2018-11-05

• The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial, 2021-10-28

• Associations of Body Size and Composition with Subclinical Cardiac Dysfunction in Older Individuals: The Cardiovascular Health Study, 2021-08-04

• Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER, 2022-08-27

• Phenomapping for Novel Classification of Heart Failure with Preserved Ejection Fraction, 2014-11-14

• ASSOCIATIONS OF MACRO- AND MICROVASCULAR ENDOTHELIAL DYSFUNCTION WITH SUBCLINICAL VENTRICULAR DYSFUNCTION IN END-STAGE RENAL DISEASE, 2016-08-22

• Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study, 2021-07-13

• Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations, 2017-03-17

• Burden of Systolic and Diastolic Left Ventricular Dysfunction among Hispanics in the United States: Insights from the Echocardiographic Study of Latinos (ECHO-SOL), 2016-02-20

• Physical Activity and Prognosis in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial, 2017-06-21

• Association of Sodium Intake with Adverse Cardiac Structure and Function: From the HyperGEN Study, 2017-08-08

• Right Heart Structural Changes Are Independently Associated with Exercise Capacity in Non-Severe COPD, 2011-12-29

• Association of Serum Triiodothyronine with B-type Natriuretic Peptide and Severe Left Ventricular Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction, 2012-04-11

• Magnetic Resonance and Computed Tomography Imaging for the Evaluation of Pulmonary Hypertension, 2016-04-07

• Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction, 2017-10-25

• Age dependent associations of risk factors with heart failure: pooled population based cohort study, 2021-03-23

• The future of heart failure with preserved ejection fraction Deep phenotyping for targeted therapeutics Perspektiven bei Herzinsuffizienz mit erhaltener Ejektionsfraktion Zielgerichtete Therapie durch tiefe Phanotypisierung, 2022-06-29

• Pulmonary Hypertension is Associated with a Higher Risk of Heart Failure Hospitalization and Mortality in Patients with Chronic Kidney Disease: The Jackson Heart Study, 2017-05-24

• Comparison of Echocardiographic Measures in a Hispanic/Latino Population with the 2005 and 2015 American Society of Echocardiography Reference Limits [The Echocardiographic Study of Latinos (ECHO-SOL)] Qureshi et al: Echocardiography and Cardiac Chamber Quantification, 2015-11-23

• Characterization of cardiac mechanics and incident atrial fibrillation in participants of the Cardiovascular Health Study, 2020-10-02

• Prevalence, Clinical Phenotype, and Outcomes Associated with Normal B-Type Natriuretic Peptide Levels in Heart Failure with Preserved Ejection Fraction, 2012-06-07

• Fibroblast Growth Factor 23 and Long-Term Cardiac Function: The Multi-Ethnic Study of Atherosclerosis, 2020-11-09

• Relationship Between Repolarization Heterogeneity and Abnormal Myocardial Mechanics, 2014-01-10

• Cyclic Guanosine Monophosphate and 10-Year Change in Left Ventricular Mass: the Multi-Ethnic Study of Atherosclerosis (MESA), 2021-03-09

• Genetic-Based Hypertension Subtype Identification Using Informative SNPs, 2020-10-27

• Risk-based intensive blood pressure lowering and prevention of heart failure: A SPRINT post hoc analysis, 2021-11-01

• A Non-Invasive Assessment of Cardiopulmonary Hemodynamics with MRI in Pulmonary Hypertension, 2015-08-14

• Left Atrial Strain is Associated with Adverse Cardiovascular Events in Patients with End-Stage Renal Disease: Findings from the Cardiac, Endothelial Function and Arterial Stiffness in ESRD (CERES) Study, 2022-04-06

• Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction, 2022-03-04

• Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure with Preserved Ejection Fraction: TOPCAT, 2019-06-21

• Collagen homeostasis of the left atrium: an emerging treatment target to prevent heart failure?, 2022-01-19

• Heart Failure with Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal Women, 2020-01-15

• Generation of human iPSCs from urine derived cells of patient with a novel homozygous PAI-1 mutation, 2016-11-09

• Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction, 2021-01-05

• Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis, 2023-01-12

• Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials, 2022-06-18

• Usefulness of Electrocardiographic QT Interval to Predict Left Ventricular Diastolic Dysfunction, 2011-09-10

• Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial, 2023-08-27

• Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure with Preserved Ejection Fraction: The TOPCAT Trial, 2019-01-21

• Endomyocardial Biopsy Characterization of Heart Failure with Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis, 2020-07-08

• A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-?) gene and systemic sclerosis, 2015-05-19

• Association of Impaired Glucose Regulation and Insulin Resistance With Cardiac Structure and Function: Results from ECHO-SOL, 2016-09-21

• Inclusion Criteria for HFpEF Clinical Trials: Making the Case for Precision Diagnosis and Greater Inclusivity, 2022-03-21

• Role of PAI-1 in hepatic steatosis and dyslipidemia, 2021-01-11

• Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week, 2022-05-10

• Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study, 2021-11-29

• The Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure with Preserved Ejection Fraction and the Impact of Spironolactone, 2015-10-16

• Antihypertensive Class and Cardiovascular Outcomes in Patients with HIV and Hypertension, 2021-04-05

• Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women, 2018-06-05

• Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life, 2020-03-16

• Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis, 2023-04-04

• Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure, 2020-06-29

• Matchmaking for the Optimization of Heart Failure with Preserved Ejection Fraction Clinical Trials: No Laughing Matter, 2013-07-31

• Genotype and Phenotype of Transthyretin Cardiac Amyloidosis in the United States: The Transthyretin Amyloid Outcome Survey (THAOS), 2016-07-12

• Diastolic wall strain: a simple marker of abnormal cardiac mechanics, 2014-10-03

• Favorable Levels of All Major Cardiovascular Risk Factors at Younger Ages and High-Sensitivity C-Reactive Protein 39 Years Later -The Chicago Healthy Aging Study, 2015-04-08

• 10-Year Risk Equations for Incident Heart Failure in the General Population, 2019-05-21

• The Association Between Myocardial Strain and Frailty in the Cardiovascular Health Study, 2020-12-16

• Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure, 2020-11-03

• Relation of Short-Term Heart Rate Variability to Incident Heart Failure (From the Multi-Ethnic Study of Atherosclerosis), 2013-05-16

• Predictive Accuracy of Heart Failure-Specific Risk Equations in an Electronic Health Record-Based Cohort, 2020-10-23

• Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations with Cardiac Structure/Function and Natriuretic Peptides (The Multi-Ethnic Study of Atherosclerosis), 2016-11-23

• Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure, 2020-09-22

• Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate, 2015-07-28

• Tensor Factorization for Precision Medicine in Heart Failure with Preserved Ejection Fraction, 2017-01-23

• Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report, 2017-06-26

• Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction, 2017-09-26

• The Prognostic Importance of Impaired Systolic Function in Heart Failure with Preserved Ejection Fraction and the Impact of Spironolactone, 2015-06-30

• Reduced hemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertension, 2016-08-26

• Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction, 2022-09-13